---
layout: minimal-medicine
title: Antihemophilic Factor VIII Fc Fusion Protein Recombinant
---

# Antihemophilic Factor VIII Fc Fusion Protein Recombinant
### Generic Name
Antihemophilic Factor VIII Fc Fusion Protein Recombinant

### Usage

Antihemophilic Factor VIII Fc fusion protein (recombinant) is a medication used to treat Hemophilia A in adults and children.  Hemophilia A is a bleeding disorder caused by a deficiency in Factor VIII, a crucial protein involved in blood clotting. This medicine works by replacing the missing Factor VIII, thereby helping to control and prevent bleeding episodes.  Its primary use is in on-demand treatment of bleeding episodes, meaning it's given when a bleed occurs.  It's also used for perioperative management of bleeding (before, during, and after surgery) and for routine prophylaxis (preventative treatment) to reduce the frequency of bleeds.  Importantly, this medication is *not* indicated for the treatment of von Willebrand disease.


### Dosage

Dosage is calculated based on the individual's weight and the severity of the bleeding.  The goal is to raise the plasma Factor VIII level to a specific target, which varies depending on the type and severity of the bleed.  Here's a summary; however, *always refer to your doctor's instructions and the specific product labeling for precise dosing*:

**Adults:**

* **On-demand treatment (bleeding episodes):** The dose varies from 20-50 IU/kg depending on whether the bleed is minor/moderate or major (life-threatening).  The frequency of administration also depends on the severityâ€”potentially every 12-48 hours until the bleeding stops.

* **Perioperative management (surgery):**  Dosing depends on the type of surgery (minor or major).  A preoperative dose is usually given, followed by additional doses to maintain a target Factor VIII level for several days after the procedure.

* **Routine prophylaxis (prevention):**  A typical dose is 50 IU/kg every 4 days, but this can be adjusted based on individual response, ranging from 25-65 IU/kg at 3-5 day intervals.

**Children:**

Dosing for children is similar to adults, but children under 6 years of age may require higher doses or more frequent administration.  The specific regimen will be determined by a healthcare professional based on individual needs and coagulation studies.


**Administration:**  The medication is administered intravenously (IV).  The infusion rate should not exceed 10 mL/min (although some sources suggest a rate not exceeding 3 mL/min).

### Side Effects

Common side effects (occurring in more than 10% of patients) may include increased risk of developing Factor VIII inhibitors (antibodies that block the drug's effectiveness).

Less common side effects (1-10% of patients) may include:

* Catheter-site thrombosis
* Papular rash

Rare side effects (<1% of patients) can include:

* Dizziness, headache, malaise, feeling hot or cold
* Chest pain, deep vein thrombosis, flushing, hypertension, hypotension
* Dysgeusia (altered taste), lower abdominal pain
* Skin rash, injection-site reactions
* Arthralgia (joint pain), back pain, joint swelling, myalgia (muscle pain)
* Cough

Post-marketing surveillance has also identified hypersensitivity reactions as a potential side effect.

**Important:** If any adverse effects occur, contact a healthcare provider immediately.

### How it Works

Antihemophilic Factor VIII Fc fusion protein (recombinant) is a genetically engineered version of Factor VIII. It temporarily replaces the missing Factor VIII in individuals with Hemophilia A. This replacement allows for proper blood clot formation, thereby stopping or preventing bleeding episodes.  The fusion with the Fc region of human immunoglobulin G1 (IgG1) enhances the drug's half-life, meaning it stays in the bloodstream longer, requiring less frequent dosing.


### Precautions

* **Contraindications:** This medication is contraindicated in patients with a history of life-threatening hypersensitivity reactions to the drug or its components.

* **Hypersensitivity:** There's an increased risk of hypersensitivity reactions, including anaphylaxis (a severe, life-threatening allergic reaction).

* **Inhibitor Formation:**  The development of neutralizing antibodies (inhibitors) against Factor VIII is a potential complication.

* **Pregnancy and Breastfeeding:**  The medication is categorized as Pregnancy Category C, meaning the risks to the mother and fetus are unknown.  Use during pregnancy should be carefully considered, only when the benefits outweigh the potential risks.  The excretion of this medication in breast milk is unknown.


* **Other Precautions:**  Patients with hepatic or renal impairment generally do not require dosage adjustments, but this should always be discussed with a healthcare professional.

### FAQs

* **Q: How long does it take to work?** A: The onset of action varies depending on the dose and individual response, but it typically works relatively quickly to control bleeding.

* **Q: How is it stored?** A: Storage instructions vary depending on the specific product; always refer to the product label for proper storage conditions.

* **Q: What should I do if I miss a dose?** A: Contact your healthcare provider immediately to determine the appropriate course of action.  This is particularly important for prophylactic use.

* **Q: Can I take other medications with this one?** A:  Inform your healthcare provider of all medications you are taking, including over-the-counter drugs and herbal supplements, to assess for potential interactions, although no significant interactions are currently reported in product labeling.

* **Q: Are there long-term effects?** A:  Long-term effects are primarily related to the potential for inhibitor development and the need for ongoing monitoring.

**Disclaimer:** This information is intended for general knowledge and does not constitute medical advice. Always consult with a healthcare professional before starting or changing any medication.  The information provided here is based on available data and may not encompass all aspects of the drug. Always refer to the complete prescribing information for the specific product you are using.
